# The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

> **NCT05266534** · NA · RECRUITING · sponsor: **Wael Elbanna Clinic** · enrollment: 162 (estimated)

## Conditions studied

- Myoma

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Carbetocin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05266534
- **Lead sponsor:** Wael Elbanna Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266534, "The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05266534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*